Australia markets closed

PEPTONIC medical AB (publ) (28L.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.00040.0000 (0.00%)
At close: 08:06AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 1.95M
Enterprise value 1.57M
Trailing P/E 0.66
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.14
Price/book (mrq)0.09
Enterprise value/revenue 0.04
Enterprise value/EBITDA -0.07

Trading information

Stock price history

Beta (5Y monthly) 0.18
52-week change 3-93.10%
S&P500 52-week change 322.38%
52-week high 30.0078
52-week low 30.0002
50-day moving average 30.0029
200-day moving average 30.0043

Share statistics

Avg vol (3-month) 31.64k
Avg vol (10-day) 310.01k
Shares outstanding 51.53B
Implied shares outstanding 64.87B
Float 81.17B
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in SEK.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin -76.50%
Operating margin (ttm)-79.34%

Management effectiveness

Return on assets (ttm)-19.77%
Return on equity (ttm)-46.48%

Income statement

Revenue (ttm)40.52M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)-21.80%
Gross profit (ttm)N/A
EBITDA -45.24M
Net income avi to common (ttm)-31M
Diluted EPS (ttm)0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.7M
Total cash per share (mrq)0.01
Total debt (mrq)5.16M
Total debt/equity (mrq)6.74%
Current ratio (mrq)2.76
Book value per share (mrq)0.72

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A